The Barbara Ann Karmanos Cancer Institute in Detroit will be using Definiens Tissue Studio 2.0 in a new approach to automate tissue section and microarray analysis for cancer diagnosis and biomarker development for personalized medicine applications.

Definiens Tissue Studio will allow the researchers to analyze cancers, including lung, breast and pancreatic cancer, on the cellular and sub-cellular level. Rapid and accurate quantification of cancer characteristics will enable the research team to translate knowledge to clinical applications, said the Institute.